Blog
DGAP-News: Hannover Re increases premium volume in 1 January renewals and confirms guidance for 2020
DGAP-News: Hannover Re increases premium volume in 1 January renewals and confirms guidance for 2020
DGAP-News: Infineon Technologies AG: Q1 FY 2020: REVENUE DECLINE AS PREDICTED, SEGMENT RESULT MARGIN DEVELOPED POSITIVELY, COST-REDUCTION MEASURES TAKING EFFECT, OUTLOOK FOR 2020 FISCAL YEAR CONFIRMED
DGAP-News: Infineon Technologies AG: Q1 FY 2020: REVENUE DECLINE AS PREDICTED, SEGMENT RESULT MARGIN DEVELOPED POSITIVELY, COST-REDUCTION MEASURES TAKING EFFECT, OUTLOOK FOR 2020 FISCAL YEAR CONFIRMED
DGAP-News: Dermapharm Holding SE opens new logistics center in Brehna
DGAP-News: Dermapharm Holding SE opens new logistics center in Brehna
DGAP-News: DIC Asset AG: 2019 Annual Report confirms outstanding results of last year
DGAP-News: DIC Asset AG: 2019 Annual Report confirms outstanding results of last year
DGAP-News: HAMBORNER REIT AG reports record result - Preliminary figures show successful 2019 financial year with further growth in revenue and earnings
DGAP-News: HAMBORNER REIT AG reports record result - Preliminary figures show successful 2019 financial year with further growth in revenue and earnings
Full year and fourth quarter 2019 results
Full year and fourth quarter 2019 results
Aperam announces dividend payment schedule for 2020
Aperam announces dividend payment schedule for 2020
Aperam announces a share buyback program
Aperam announces a share buyback program
DGAP-News: BaFin finds Ontake Research in breach of section 86 (1) German Securities Trading Act (WpHG).
DGAP-News: BaFin finds Ontake Research in breach of section 86 (1) German Securities Trading Act (WpHG).
EQS-Adhoc: Conzzeta: Interim information as of the end of 2019
EQS-Adhoc: Conzzeta: Interim information as of the end of 2019
DGAP-Adhoc: Villeroy & Boch AG: Announcement of the dividend proposal
DGAP-Adhoc: Villeroy & Boch AG: Announcement of the dividend proposal
DGAP-News: Formycon informs about the current Status of the BLA Review Process of the Lucentis(R)* Biosimilar Candidate FYB201
DGAP-News: Formycon informs about the current Status of the BLA Review Process of the Lucentis(R)* Biosimilar Candidate FYB201
DGAP-News: MorphoSys Initiates Expanded Access Program for Tafasitamab in the U.S.
DGAP-News: MorphoSys Initiates Expanded Access Program for Tafasitamab in the U.S.
DGAP-News: Mynaric raises EUR 12M to ramp up further production of laser communication products
DGAP-News: Mynaric raises EUR 12M to ramp up further production of laser communication products
DGAP-Adhoc: Mynaric AG: Successful completion of capital increase
DGAP-Adhoc: Mynaric AG: Successful completion of capital increase
DGAP-News: CPI PROPERTY GROUP - Globalworth Investment and Strategy Update
DGAP-News: CPI PROPERTY GROUP - Globalworth Investment and Strategy Update
DGAP-News: DIC Asset AG: Supervisory Board Confirms Management Team in its Roles and Renews Board Appointments of Sonja Wärntges, CEO, and Johannes von Mutius, CIO
DGAP-News: DIC Asset AG: Supervisory Board Confirms Management Team in its Roles and Renews Board Appointments of Sonja Wärntges, CEO, and Johannes von Mutius, CIO
Turkiye Garanti Bankasi A.S.: TRFGRAN22012 ISIN- Redemption of the Debt Instrument
Turkiye Garanti Bankasi A.S.: TRFGRAN22012 ISIN- Redemption of the Debt Instrument
Turkiye Garanti Bankasi A.S.: Changes in Top Management
Turkiye Garanti Bankasi A.S.: Changes in Top Management
Royal KPN N.V. Press Release: Members of Board of Management buy KPN shares
Royal KPN N.V. Press Release: Members of Board of Management buy KPN shares
DGAP-Adhoc: Mynaric AG: Implementation of a capital increase from authorized capital resolved
DGAP-Adhoc: Mynaric AG: Implementation of a capital increase from authorized capital resolved
Travis Perkins: Director / PDMR Shareholding
Travis Perkins: Director / PDMR Shareholding
Travis Perkins: Total Voting Rights
Travis Perkins: Total Voting Rights
Magnit Announces the Coupon Yield Payment
Magnit Announces the Coupon Yield Payment
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL


